Skip to main content
. 2009 May 19;100(12):1966–1974. doi: 10.1038/sj.bjc.6605097

Table 1. Distribution of ApoE genotypes by cases and controls.

Variable All cases N (%) Controls N (%) P-value OR (95% CI) all cases vs controls
ApoE4            
 TT 568 (75.0) 634 (73.4) 0.56 1.00 (Referent)
 CT 172 (22.7) 204 (23.6)   0.94 (0.75, 1.19)
 CC 17 (2.2) 26 (3.0)   0.73 (0.39, 1.36)
         
ApoE2            
 TT 673 (86.4) 779 (85.5) 0.69 1.00 (Referent)
 CT 103 (13.2) 126 (13.8)   0.95 (0.72, 1.25)
 CC 3 (0.4) 6 (0.7)   0.58 (0.14, 2.32)
             
  MSS/L N (%) MSI-H N (%)     OR (95% CI) MSS/L vs controls OR (95% CI) MSI-H vs controls
ApoE4            
 TT 391 (75.0) 63 (73.3) 634 (73.4) 0.85 1.00 (Referent) 1.00 (Referent)
 CT 119 (22.8) 20 (23.3) 204 (23.6)   0.95 (0.73, 1.23) 0.99 (0.58, 1.67)
 CC 11 (2.1) 3 (3.5) 26 (3.0)   0.69 (0.34, 1.40) 1.16 (0.34, 3.94)
             
ApoE2            
 TT 541 (86.8) 94 (84.7) 779 (85.5) 0.70 1.00 (Referent) 1.00 (Referent)
 CT/CC 82 (13.2) 17 (15.3) 132 (14.5)   0.89 (0.66, 1.20) 1.07 (0.62, 1.85)

ApoE2 represents ApoE protein with 112Cys/158Cys residues, ApoE4 represents ApoE protein with 112Arg/158Arg residues, MSI-H=high frequency microsatellite instability, MSS/L=microsatellite stable/low-frequency microsatellite instability, homozygous wild-type allele carriers were considered as the referent groups.